Shirley XuSite Supply Chain Head
9:00 AM Opening Remarks from Chairperson
9:20 AM Interpreting the Regulation Updates that Empower the Revolution of Biopharma Supply Chain in China
· Understanding the latest regulation updates and trends.
· Constraints vs. Opportunities: Identifying the China-specific regulatory requirements that have impacts on biopharma supply chain strategy
· New role of GSP enterprises reacting to the new regulation
· Striking the right balance between cost, quality and compliance